Cross-linking Reagents for Protein Complex Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cross-linking reagents for protein interactions suffer from inefficiencies, slow kinetics, and structural destabilization, particularly in analyzing high molecular weight protein complexes, due to their dependence on quaternary structure and extended incubation times, which can lead to artifactual results and limited detection sensitivity.
Innovation Solution
The use of novel cross-linking reagents such as 1,1'-(suberoyldioxy)bisbenzotriazole (SBBT) and 1,1'-(suberoyldioxy)bisazabenzotriazole (SBAT), which offer improved efficiency and kinetic properties, allowing for faster and more reliable cross-linking of proteins and other compounds, even in aqueous solutions, enabling better detection of intact protein complexes using High-Mass MALDI mass spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If typical cross-linking reagents of the state of the art are used, then cross-linking reaction can be performed, but the reaction kinetics are slow and efficiency is low requiring extended incubation times
Solution Approach 1:
The patent modifies the chemical structure of cross-linking reagents by introducing electron-withdrawing groups (such as fluorine atoms) adjacent to the reactive ester carbonyl groups. This parameter change in molecular structure increases the electrophilicity of the carbonyl carbon, thereby accelerating the reaction kinetics with nucleophilic amino acid side chains without requiring extended incubation times.
Solution Approach 2:
The invention creates composite cross-linking reagents that combine highly reactive ester functions with electron-withdrawing substituents in a single molecular structure. This composite design achieves both fast reaction kinetics and high cross-linking efficiency, resolving the contradiction between reaction speed and completeness.
2Productivity
If extended incubation times are used to improve cross-linking efficiency, then more complete reaction occurs, but structural destabilization and artifactual results increase
Solution Approach 1:
By changing the chemical parameters of the cross-linking reagent (introducing electron-withdrawing groups), the reaction reaches completion much faster. This eliminates the need for extended incubation that would otherwise cause structural destabilization of the protein complex, thereby maintaining reliability while achieving high efficiency.
3Quantity of substance
If many nucleophilic side chains are substantially modified during extended incubation, then cross-linking coverage increases, but artifactual results due to structural destabilization occur
Solution Approach 1:
The modified reagents achieve high cross-linking coverage in short timeframes due to their enhanced reactivity. This prevents the accumulation of artifactual modifications that would occur during extended incubation, thereby maintaining result accuracy while achieving comprehensive coverage.
4Productivity
If state of the art cross-linkers are used, then cross-linking can be performed, but specificity is low leading to non-specific binding
Solution Approach 1:
The patent introduces specific chemical features (electron-withdrawing groups) at localized positions in the reagent structure near the reactive ester functions. This local modification enhances the electrophilicity and reactivity specifically at the reaction site, improving specificity without affecting the overall cross-linking capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These reagents enhance the detection and characterization of supramolecular target-ligand complexes by increasing the efficiency and speed of cross-linking reactions, providing higher sensitivity and reliability in analyzing both purified and heterogeneous biological samples, thereby overcoming the limitations of existing cross-linking methods.
Implementation Method 1
Chemical cross-linking has been largely used for more than twenty years for analyzing protein interactions allowing the stabilization of these fragile supramolecular structures
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
The invention describes the use of particular cross-linking reagents containing 1-hydroxybenzotriazole or 1-hydroxy-7-azabenzotriazole groups as reactive groups for cross-linking reactions of supramolecular target-ligand-complexes. The resulting cross-linked products may be directly analyzed using mass spectrometry, gel or fluorescence based technologies, X-ray crystallography, NMR or other analytical technologies. The method using High-Mass MALDI mass spectrometry provides various biological applications such as characterization of antibodies, drug discovery, and protein complex analysis including automated or higher throughput applications.